glp 1 ra injection GLP-1 Key Facts Novo Nordisk promotes new GLP-1

investigated the regulatory effect of epithalon on the production of melatonin and cortisol in senescent monkeys, finding that the peptide significantly stimulated melatonin synthesis, thus normalizing the circadian rhythm of cortisol secretion [11]

Further analysis found no significant differences in the hazard of negative control outcomes, including hernia, and traumatic brain injury, between the combination and monotherapy groups (Supplementary Table 5)

Statistical analysis Data are expressed as the mean SEM

Reports on safety concerns included observational data suggesting that GLP-1 RAs, especially the more potent agents are not associated with significantly increased risks for pancreatitis or medullary thyroid carcinoma

Are there risks associated with these therapies